center            center

Cambridge, UK: 31st July 2019



Life Sciences industry company operations and communications expert joins the region’s Life Science & Healthcare membership organisation


Westbury, NY – July 23, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today outlined several scientific contributions that it will be making at the 12th International ISSX Meeting. This conference will be held from July 28-31 at the Oregon Convention Center in Portland, OR.

The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence program, COT-143. The therapy is designed to help the body tackle Pseudomonas aeruginosa infections, a hard to treat drug-resistant pathogen recognised by the WHO as a critical threat to human health.

AMSBIO has introduced a new range of homogeneous proximity assays, critical enzymes and small molecule inhibitors to assess the chemical adaptor function of Proteolysis Targeting Chimeras (PROTACs).

Closed Loop Medicine (CLM) announces £1.3m grant funding from Innovate UK, Longwall Capital and IQ Capital as part of today’s IUK £16m funding announcement.

CLM is an early stage UK therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised therapy regimens underpinned by digital health solutions. 

Research Triangle Park, NC, USA and Cambridge, UK, and Lyon, France,  July 18, 2019 -- Inivata, a leader in liquid biopsy, and the Centre Léon Bérard cancer center in Lyon, France, today announce the start of a randomized phase III clinical trial to evaluate time to appropriate treatment in patients with suspected metastatic lung cancer, using Inivata’s InVisionFirst®-Lung liquid biopsy test compared to standard of care tissue biopsy. This is the first interventional study for Inivata’s InVisionFirst-Lung liquid biopsy test.

Cambridge, UK, 17 July 2019: Mogrify Ltd (Mogrify), a company aiming to transform the future development of cell therapies, today announced it will host a careers day at the Bio-Innovation Centre, 25 Cambridge Science Park on Friday, 16th August 2019 from 4–6pm. The event will showcase careers in the biotech industry, specifically in cell therapy and regenerative medicine, and offer attendees the opportunity to visit the Company’s research laboratories, and meet with the founders and current employees.

Alloy Therapeutics UK Ltd are a start-up company from the USA and required lab and office space for 15 scientist with two Cat II cell biology labs, a Cat II molecular biology lab for 10, a meeting room and write up space. 

Cambridge UK: 17 July 2019 Tuspark has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.


Jul. 16, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups.